The scFv antibody specifically recognizes CD38 and targets cancer cells. It can be used in a FACS assay with a concentration of 10 nM. The assay involved incubating the antibody for 3 hours with either CD38-expressing 300-19 cells or the parental 300-19 cells (1-2×10⁵ cells per sample) in 100 μL of ice-cold RPMI-1640 medium supplemented with 2% normal goat serum.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-079 | Recombinant Anti-Human CD38 VHH Single Domain Antibody | WB, IHC, FC, FuncS | Llama VHH |
HPAB-0625-CN | Recombinant Bactrian camel Anti-CD38 Single Domain Antibody (HPAB-0625-CN) | ELISA | VHH |
HPAB-0626-CN | Recombinant Bactrian camel Anti-CD38 Single Domain Antibody (HPAB-0626-CN) | ELISA | VHH |
There are currently no Customer reviews or questions for HPAB-AP574-YC-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.